Research
Print page Print page
Switch language
Bispebjerg Hospital - a part of Copenhagen University Hospital
E-pub ahead of print

Assisted reproductive technology treatment and risk of ovarian cancer-a nationwide population-based cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Biopsying, fragmentation and autotransplantation of fresh ovarian cortical tissue in infertile women with diminished ovarian reserve

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Risk of diabetes according to male factor infertility: a register-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Early menarche, nulliparity and the risk for premature and early natural menopause

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Female exposure to phthalates and time to pregnancy: a first pregnancy planner study

    Research output: Contribution to journalJournal articleResearch

  5. No association between body mass index and sperm DNA integrity

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Racial and Sociodemographic Differences of Semen Parameters Among US Men Undergoing a Semen Analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Mortality in women treated with assisted reproductive technology treatment - addressing the healthy patient effect

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Risk of metabolic disorders in childless men: a population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Male factor infertility and risk of multiple sclerosis: A register-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • D Vassard
  • L Schmidt
  • C H Glazer
  • J Lyng Forman
  • M Kamper-Jørgensen
  • A Pinborg
View graph of relations

STUDY QUESTION: Does hormone stimulation during assisted reproductive technology (ART) treatment increase the risk of ovarian cancer?

SUMMARY ANSWER: No increased risk of ovarian cancer was found among ART-treated women, with the exception of ART-treated women with endometriosis.

WHAT IS KNOWN ALREADY: Previous studies on the association between ovarian stimulation during ART and ovarian cancer have shown conflicting results. The risk of ovarian cancer varies according to the cause of infertility, and only a few studies on ART treatment and risk of ovarian cancer have had sufficient data to address this issue. Endometriosis has been linked to an increased risk of ovarian cancer.

STUDY DESIGN, SIZE, DURATION: Women undergoing ART treatment during 1994-2015 were registered in the Danish IVF register. Data were linked with data from the Danish Cancer Register and socio-demographic population registers using an individual person identification number assigned to people residing in Denmark.

PARTICIPANTS/MATERIALS, SETTING, METHODS: All women undergoing ART treatment were age-matched with a random sample of the female background population and followed for up to 22 years. After relevant exclusions, the population consisted of 58 472 ART-treated women and 625 330 untreated women, all with no previous malignancies. Ovarian cancer risk was assessed using multivariable cox regression analyses with adjustment for educational level, marital status, parity and treatment year. Results are shown as hazard ratios (HRs) with corresponding CIs.

MAIN RESULTS AND THE ROLE OF CHANCE: In total, 393 (0.06%) women were diagnosed with ovarian cancer during follow-up (mean 9.7 years). Women treated with ART had an increased risk of ovarian cancer (HR 1.20, 95% CI 1.10-1.31), which diminished over time. The increased risk was apparent among women with female factor infertility (HR 1.36, 95% CI 1.25-1.48), whereas no female factor infertility was associated with a lower risk (HR 0.87, 95% CI 0.76-1.00). The risk was increased among women with endometriosis (HR 3.78, 95% CI 2.45-5.84), whereas no increased risk was found among ART-treated women with polycystic ovary syndrome, other female causes of infertility and unexplained infertility.

LIMITATIONS, REASONS FOR CAUTION: The association between ART treatment and ovarian cancer is likely influenced by increased detection due to multiple ultrasound scans during ART treatment.

WIDER IMPLICATIONS OF THE FINDINGS: Undergoing ART treatment without the presence of endometriosis was not associated with an increased risk of ovarian cancer, which is reassuring. Whether ART treatment increases the risk of ovarian cancer among women with endometriosis needs further investigation.

STUDY FUNDING/COMPETING INTEREST(S): This work was supported by a PhD grant to D.V. from the Faculty of Health and Medical Sciences, University of Copenhagen, Denmark. Funding for establishing the Danish National ART-couple II cohort was achieved from Ebba Rosa Hansen Foundation. The funders had no influence on data collection, analyses or results presented. The authors have no conflicts of interest to declare.

Original languageEnglish
JournalHuman reproduction (Oxford, England)
ISSN0268-1161
DOIs
Publication statusE-pub ahead of print - 10 Oct 2019

ID: 58288301